P21 Releases New PMDA Validation Engine
New PMDA Engine Pinnacle 21 is happy to announce the latest Validation Engine for submissions…
Certara2021 年 12 月 20 日
Certara Launches Fellowship Program in Africa for Applied Pharmacometrics Training
PRINCETON, N.J.— 2021 年 11 月 8 日 -- Certara, Inc, a global leader in biosimulation, today announced…
Certara2021 年 11 月 8 日
New Pinnacle 21 Community Validation Engine: FDA (1907.2)
In August 2020, we released our new Pinnacle 21 validation engine “FDA (1907.2)” for preparing…
Certara2020 年 9 月 13 日
Introducing P21 Community 3.0
2019 年 5 月 7 日 We are thrilled to announce that P21 Community 3.0 is available for immediate…
Certara2019 年 5 月 7 日
New Pinnacle 21 Enterprise 4.0 Eases Concern about PMDA Submissions
2019 年 4 月 2 日 Released March 31, the new P21 Enterprise 4.0 provides more options for…
Certara2019 年 4 月 2 日
What’s New in Enterprise 3.4 Q&A
Is there documented guidance on the creation of the sponsor SDTM metadata to be uploaded…
Certara2018 年 5 月 17 日
Pinnacle 21 Wins TOPRA Award for Regulatory Excellence in Innovation
Certara’s Pinnacle 21 is honored to announce that Max Kanevsky, has been named to the…
Certara2016 年 12 月 1 日
Introducing OpenCDISC Enterprise 3.0
Pinnacle 21 is proud to announce the launch of OpenCDISC Enterprise 3.0, which will be…
Certara2015 年 10 月 27 日
Max Kanevsky named to the PharmaVOICE 100 List of the Most Inspiring People
Certara’s Pinnacle 21 is honored to announce that Max Kanevsky, has been named to the…
Certara2015 年 8 月 5 日
